PreserFlo™ MicroShunt Versus Trabeculectomy in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study

作者
Sofia Fili,Kalliopi Kontopoulou,Iraklis Vastardis,Georgios Perdikakis,Markus Kohlhaas
出处
期刊:Cureus [Cureus, Inc.]
卷期号:14 (8): e28288-e28288 被引量:25
标识
DOI:10.7759/cureus.28288
摘要

PURPOSE: The study compares the efficacy and safety of PreserFlo™ MicroShunt (Santen, Osaka, Japan) and trabeculectomy in eyes with moderate to advanced open-angle glaucoma. METHODS: In this prospective study, 300 patients (300 eyes) with moderate to advanced open-angle glaucoma were treated with either PreserFlo MicroShunt or trabeculectomy. The implantation of the PreserFlo MicroShunt was performed in 150 eyes (group A) and trabeculectomy was performed in 150 eyes (group B). The efficacy was evaluated by estimating the absolute and qualified success rates using the Kaplan-Meier survival analysis. Results: During the 12-month follow-up period, 81.33% of eyes in group A and 94% in group B reduced intraocular pressure (IOP) >20% without glaucoma eye drops. The average IOP 12 months after surgery was 12.89±3.4 mmHg in group A and 11.39±4.5 mmHg in group B, which was significantly lower than the baseline intraocular pressure (group A: 23.47±8.36 mmHg, p=0.00053; group B: 22.03±5.2 mmHg, p= 0.0006). The number of topical medications administered 12 months after ocular surgery was 0.4±0.8 in group A and 0 in group B, compared to 2.5±1.2 in group A and 2.7±0.9 in group B at baseline (group A: p= 0.00091; group B: p= 0.00072). Ten eyes (6.67%) in group A and four eyes (2.67%) in group B were referred for bleb revision due to bleb fibrosis and consequent acute postoperative rise in IOP. Four eyes of group A and two eyes of group B were treated with transscleral cyclophotocoagulation. Five eyes in group B received re-trabeculectomy because of dysfunction of the primary bleb. CONCLUSION: PreserFlo MicroShunt reduced the number of antiglaucoma agents compared to baseline, but was inferior to trabeculectomy at reducing IOP after 12 months. Additionally, trabeculectomy produced better absolute success rates after 12 months than PreserFlo MicroShunt in the treatment of moderate to advanced open-angle glaucoma.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
勤奋一一的应助被温暖的鹏飞采纳,获得10
1秒前
研友_nEoEy8完成签到,获得积分10
1秒前
羊羊羊完成签到,获得积分10
1秒前
2秒前
3秒前
3秒前
可爱的函函的应助被赛特新思采纳,获得20
4秒前
核桃的应助被BINGO采纳,获得30
4秒前
4秒前
4秒前
4秒前
费可发布了新的文献求助10
4秒前
znn完成签到,获得积分10
5秒前
养只缅因完成签到,获得积分10
5秒前
5秒前
橙子完成签到,获得积分10
6秒前
6秒前
行则将至完成签到,获得积分10
7秒前
初景的应助被柚子采纳,获得20
7秒前
缓慢寒梅发布了新的文献求助20
8秒前
科研通AI6.2的应助被ygj采纳,获得10
8秒前
源代码发布了新的文献求助10
8秒前
jiangyang发布了新的文献求助20
8秒前
9秒前
陶醉发布了新的文献求助10
9秒前
遇见完成签到,获得积分10
9秒前
hrs发布了新的文献求助10
9秒前
9秒前
10秒前
悲凉的素完成签到,获得积分10
10秒前
脑洞疼的应助被谨慎的秋烟采纳,获得100
10秒前
11秒前
12秒前
王珑发布了新的文献求助10
12秒前
yi发布了新的文献求助10
13秒前
陶醉的嘉熙完成签到,获得积分10
13秒前
贾文浩发布了新的文献求助10
16秒前
kk完成签到,获得积分10
16秒前
竹马子发布了新的文献求助10
16秒前
乐乐的应助被帅气诗槐采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8168144
求助须知:如何正确求助?哪些是违规求助? 9561199
关于积分的说明 21759542
捐赠科研通 7759434
什么是DOI,文献DOI怎么找? 3429948
关于科研通互助平台的介绍 2553742
邀请新用户注册赠送积分活动 2474463